A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc.
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Advaxis, Inc.
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Syndax Pharmaceuticals
The Methodist Hospital Research Institute
H. Lee Moffitt Cancer Center and Research Institute
VA Office of Research and Development